Arlington Partners’s LivaNova LIVN Stock Holding History

Arlington Partners’s Portfolio LIVN Stock Details LIVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-912	Closed	-$67K	–	357
2021 Q1	$67K	Buy	+912	New	+$65.1K	0.02%	196

Other funds holding LIVN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

HRCM

Hawk Ridge Capital Management Los Angeles, California $2.75B AUM 20.09% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Arlington Partners's LIVN Position: Q2 2021 in Review

Arlington Partners sold out of LivaNova (LIVN) in Q2 2021, closing a stake of 912 shares — an estimated $67K sold.

Arlington Partners first reported a position in LIVN in Q1 2021 and held it in 1 quarter. The position peaked at $67K in Q1 2021. 211 funds tracked by Wall St. Rank hold LIVN as of Q2 2021.

Arlington Partners reported no remaining LivaNova position as of Q2 2021 after selling out during the quarter.
Arlington Partners sold 912 LivaNova shares in Q2 2021, an estimated $67K.
Arlington Partners first reported a position in LivaNova in Q1 2021 and held it in 1 quarter.
Arlington Partners's LivaNova position peaked at $67K in Q1 2021.
211 funds tracked by Wall St. Rank held LivaNova as of Q2 2021.

Based on Arlington Partners's 13F filing for Q2 2021, filed 7 Jul 2021.